AI in Clinical Practice: transforming the detection and diagnosis of lung cancer
Listen to our webinar on how AI is transforming cancer detection, diagnosis, and researchโenhancing precision, streamlining workflows, and improving patient outcomes.
Generating oncology real-world evidence outside the U.S. is complex. Limited access to representative patient data, concerns over quality and completeness, and diverse privacy regulations make it difficult to produce reliable, timely insights. Traditional sources such as registries and claims data are useful but often too limited for todayโs oncology research needs.
To address these challenges, forward-looking organizations are adopting new approaches. Multi-hospital collaborations and trusted data partner networks are expanding access and representation. Commissioned cohorts allow researchers to study specific populations such as biomarker-defined groups. Harmonized data models and regular updates are enabling faster, more relevant insights across countries and healthcare systems.
Secure Data Environment (SDE) platforms now give hospitals confidence to contribute data safely and compliantly. AI and machine learning tools are improving data quality, reducing site workload, and unlocking value from underused data sources like unstructured EMR notes. These advances are helping generate oncology RWE at scale across Europe and APAC.
The demand for oncology real-world evidence is growing. Regulators and HTA agencies are increasingly open to its use, making early engagement and the right data strategies critical for success.
At BC Platforms, we help partners generate clinically-rich, representative, and harmonized oncology RWE, building the foundation for faster, more impactful oncology research.